Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study

In a prospective cohort study in subfertile women with elevated basal FSH levels, AMH is identified as a marker for actual fertility.

Like Comment

Authors

Felicia Yarde, M.D., Marlies Voorhuis, M.D., Madeleine Dólleman, M.D., Erik A.H. Knauff, M.D., Ph.D., Marinus J.C. Eijkemans, M.Sc., Frank J.M. Broekmans, M.D., Ph.D.

Volume 100, Issue 3, Pages 831-838.e2, September 2013

Abstract

Objective:

To investigate the role of serum antimüllerian hormone (AMH) as a predictor of live birth and reproductive stage in subfertile women with elevated basal FSH levels.

Design:

A prospective observational cohort study conducted between February 2005 and June 2009.

Setting:

Tertiary fertility center.

Patient(s):

Subfertile women with [1] a regular menstrual cycle (mean cycle length 25–35 days); [2] basal FSH concentrations ≥12.3 IU/L; and [3] younger than 40 years (n = 96).

Intervention(s):

None.

Main Outcome Measure(s):

Live birth and reproductive stage according to the Stages of Reproductive Aging Workshop.

Result(s):

A cumulative live birth rate of 63.5% was observed during a median follow-up of 3.3 years (n = 85). The AMH level was significantly associated with live birth. There was evidence of a nonlinear prediction pattern, with an increase in chances of live birth until an AMH level of 1 μg/L. Other ovarian reserve tests and chronological age appeared of limited value in predicting live birth. In addition, AMH was significantly associated with the timing of reproductive stages (n = 68) (i.e., the occurrence of menopausal transition or menopause during follow-up).

Conclusion(s):

The present findings suggest applicability of AMH determination as a marker for actual fertility in subfertile women with elevated basal FSH levels.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00607-9/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.